Biotech
Human history has been all but defined by death and disease, plague and pandemic. Advancements in 20th century medicine changed all of that. Now advancements in 21st century medicine promise to go even further. Could we bring about an end to disease? Reverse aging? Give hearing to the deaf and sight to the blind? The answer may be yes. And soon.
More
New water purification tablet makes river water safe to drink
A new water purification tablet that simply and quickly decontaminates river water could help address global drinking water scarcity.
Surgeons connected a pig kidney to a human
Scientists linked a pig’s kidney to a human body for the first time. This breakthrough experiment marks one step closer toward the goal of using animal organs for life-saving transplants.
Ear sensor can monitor COVID-19 patients remotely
An ear sensor successfully alerted doctors to signs that COVID-19 patients isolating at home were getting worse and should be hospitalized.
Smart microscope slides make breast cancer cells leap off screen
Breast cancer cells appear brightly colored when placed on new smart microscope slides, which could help doctors diagnose patients earlier.
CRISPR is revolutionizing medicine — its origin story is pretty incredible, too
The origin story of CRISPR highlights how groundbreaking discoveries can emerge from run-of-the-mill research.
New cardiac patch can be implanted with a syringe
A new cardiac patch developed by Canadian scientists could help repair heart damage by supporting tissue without blocking electrical activity.
Brain implant relieves woman’s treatment-resistant depression
A woman with severe treatment-resistant depression has found relief, thanks to “pacemaker” implanted in her brain by UCSF researchers.
Here’s why sensory perception research was awarded a Nobel Prize
Physiologists David Julius and Ardem Patapoutian were awarded the Nobel Prize in Medicine for their research on human sensory perception.
Therapy can relieve chronic back pain by rewiring the brain
A psychological treatment for chronic back pain left two-thirds of study participants with little-to-no pain after just one month.
WHO recommends its first malaria vaccine
A malaria vaccine developed by GlaxoSmithKline, Mosquirix, has been recommended for use by the World Health Organization.
CRISPR partially restores vision in colorblind people
Scientists used CRISPR to direct edit DNA inside a healthy human cell, restoring partial vision to blind people.
Wearable health monitors help predict flu before symptoms start
A human challenge trial suggests that wearable health monitors could help predict flu and cold infections before symptoms appear.
This gene-edited tomato may help lower your blood pressure
A gene-edited tomato that may be able to lower your blood pressure is the first CRISPR-edited food to be sold commercially.
An at-home test to find your best birth control option
Seattle-based startup adyn is developing an at-home testing kit to help women find their best birth control method.
Gene-edited fish grow up to 60% more muscle
A gene-edited fish that grows up to 60% more muscle on the same amount of feed could help revitalize Japan’s aquaculture industry.
Pill to treat COVID-19 cuts risk of hospitalization or death in half
A pill to treat COVID-19 that cut hospitalizations and deaths in half could become the first oral medication against the disease.
MIT’s new bionics center may usher in our cyborg future
MIT has established a new bionics research center to help people everywhere overcome the challenges of disabilities.
Antiviral reduces COVID-19 hospitalizations by 87%
The FDA-approved antiviral drug remdesivir prevents high-risk people from ending up in the hospital, if given early.
A malaria antibody prevented infections in purposefully-infected volunteers
In a small study, researchers found an antibody that prevents malaria infection in people purposefully infected with the parasite.
Johns Hopkins has developed a lung cancer blood test
Researchers at Johns Hopkins are using AI to power a lung cancer blood test.
Subscribe to the newsletter